View in EDS HTML Full Text PDF Full Text

Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer.

Saved in:
Bibliographic Details
Title: Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer.
Authors: Klauser PC; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Dehlavi G; Department of Chemistry, Hunter College, City University of New York, New York, New York.; Graduate Center of City University of New York, New York, New York., De Franco M; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Loor A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Viray T; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Michel A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Qeriqi B; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York., Carter LM; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Carrasco SE; Laboratory of Comparative Pathology, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and Rockefeller University, New York, New York., Zeglis BM; Department of Chemistry, Hunter College, City University of New York, New York, New York.; Graduate Center of City University of New York, New York, New York., Janjigian YY; Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York; and., Lewis JS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York; lewisj2@mskcc.org.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pharmacology, Weill Cornell Medical College, New York, New York.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 765-772. Date of Electronic Publication: 2026 May 01.
Publication Type: Journal Article
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41748291
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Klauser+PC%22">Klauser PC</searchLink>; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Dehlavi+G%22">Dehlavi G</searchLink>; Department of Chemistry, Hunter College, City University of New York, New York, New York.; Graduate Center of City University of New York, New York, New York.<br /><searchLink fieldCode="AU" term="%22De+Franco+M%22">De Franco M</searchLink>; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Loor+A%22">Loor A</searchLink>; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Viray+T%22">Viray T</searchLink>; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Michel+A%22">Michel A</searchLink>; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Qeriqi+B%22">Qeriqi B</searchLink>; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22de+Stanchina+E%22">de Stanchina E</searchLink>; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Carter+LM%22">Carter LM</searchLink>; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Carrasco+SE%22">Carrasco SE</searchLink>; Laboratory of Comparative Pathology, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and Rockefeller University, New York, New York.<br /><searchLink fieldCode="AU" term="%22Zeglis+BM%22">Zeglis BM</searchLink>; Department of Chemistry, Hunter College, City University of New York, New York, New York.; Graduate Center of City University of New York, New York, New York.<br /><searchLink fieldCode="AU" term="%22Janjigian+YY%22">Janjigian YY</searchLink>; Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York; and.<br /><searchLink fieldCode="AU" term="%22Lewis+JS%22">Lewis JS</searchLink>; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York; lewisj2@mskcc.org.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pharmacology, Weill Cornell Medical College, New York, New York.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 765-772. <i>Date of Electronic Publication: </i>2026 May 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41748291
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2967/jnumed.125.271098
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 765
    Titles:
      – TitleFull: Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Klauser PC
      – PersonEntity:
          Name:
            NameFull: Dehlavi G
      – PersonEntity:
          Name:
            NameFull: De Franco M
      – PersonEntity:
          Name:
            NameFull: Loor A
      – PersonEntity:
          Name:
            NameFull: Viray T
      – PersonEntity:
          Name:
            NameFull: Michel A
      – PersonEntity:
          Name:
            NameFull: Qeriqi B
      – PersonEntity:
          Name:
            NameFull: de Stanchina E
      – PersonEntity:
          Name:
            NameFull: Carter LM
      – PersonEntity:
          Name:
            NameFull: Carrasco SE
      – PersonEntity:
          Name:
            NameFull: Zeglis BM
      – PersonEntity:
          Name:
            NameFull: Janjigian YY
      – PersonEntity:
          Name:
            NameFull: Lewis JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1535-5667
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
              Type: main
ResultId 1